Criticalkare Pharma

Hepcvel tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Hepcvel tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To treat chronic hepatitis C (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Ledikast Tablet, is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection.
This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Ledikast Tablet, or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment.

Uses
Chronic Hepatitis C virus infection.

Storage
Store the Ledikast Tablet at a controlled room temperature of (30°C).

Side Effects
Allergic reactionsHeadacheTirednessRashes

Ledviclear 400mg Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection.
This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Ledviclear 400mg Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment.

Uses
Chronic Hepatitis C virus infection.

Storage
Store the Ledviclear 400mg Tablet at a controlled room temperature of (30°C).

Side Effects
Allergic reactionsHeadacheTirednessRashes

Myhep 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Myhep 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes.

Uses
Treatment of hepatitis C virus (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Allergic reactions that affect skin and breathingHepatitis B infection reactivationBradycardia (slow heartbeat)FatigueHeadacheNauseaInsomniaDiarrheaItchingDecreased appetiteRash or skin reactions

Resof total tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Resof total tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To Treat Chronic Hepatitis C (HCV) Infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Sovihep 400mg Tablet contains the active component Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Sovihep 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes.

Uses
Treatment of hepatitis C virus (HCV) infection

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Allergic reactions that affect skin and breathingHepatitis B infection reactivationBradycardia (slow heartbeat)FatigueHeadacheNauseaInsomniaDiarrheaItchingDecreased appetiteRash or skin reactions

Velakast tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velakast tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To treat chronic hepatitis C (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Velasof tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velasof tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To treat chronic hepatitis C (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Velpaclear tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velpaclear tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To treat chronic hepatitis C (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Hepcinat plus tablet contains active agents Daclatasvir and Sofosbuvir. It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Hepcinat plus tablet. Your physician will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus.

Uses
Treatment of chronic hepatitis C virus (HCV) infection

Storage
Store at temprature between 20-25°C (68-77°F).

Side Effects
Liver problems (such as elevated liver enzymes or liver failure)Allergic reactions (such as rash or difficulty breathing)Abnormal heart rhythmsCommon:
HeadacheFatigueNauseaDiarrheaDifficulty sleeping

Hepcinat 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Hepcinat 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes.

Uses
Treatment of hepatitis C virus (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Allergic reactions that affect skin and breathingHepatitis B infection reactivationBradycardia (slow heartbeat)FatigueHeadacheNauseaInsomniaDiarrheaItchingDecreased appetiteRash or skin reactions

Ledifos Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection.
This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Ledifos Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment.

Uses
Chronic Hepatitis C virus infection.

Storage
Store the Ledifos Tablet at a controlled room temperature of (30°C).

Side Effects
Allergic reactionsHeadacheTirednessRashes

Myhep Dvir Tablet contains active agents Daclatasvir and Sofosbuvir. It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Myhep Dvir Tablet. Your physician will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus.

Uses
Treatment of chronic hepatitis C virus (HCV) infection.

Storage
Store at temprature between 20-25°C (68-77°F).

Side Effects
Liver problems (such as elevated liver enzymes or liver failure)Allergic reactions (such as rash or difficulty breathing)Abnormal heart rhythmsHeadacheFatigueNauseaDiarrheaDifficulty sleeping

Sofokast Plus tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Sofokast Plus tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness

Sofovir 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Sofovir 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes.

Uses
Treatment of hepatitis C virus (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Allergic reactions that affect skin and breathingHepatitis B infection reactivationBradycardia (slow heartbeat)FatigueHeadacheNauseaInsomniaDiarrheaItchingDecreased appetiteRash or skin reactions

Velpanat tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velpanat tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To treat chronic hepatitis C (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Velpas S tablet contains the active components Sofosbuvir and Velpatasvir.  It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velpas S tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced.

Uses
To treat chronic hepatitis C (HCV) infection.

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Hepatitis B reactivationSevere allergic reactionsHeadacheFatigueNauseaInsomniaDiarrheaItching (pruritus)Decreased appetiteMuscle or joint painRashDizziness

Viroclear 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Viroclear 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes.

Uses
Treatment of hepatitis C virus (HCV) infection

Storage
Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F).

Side Effects
Allergic reactions that affect skin and breathingHepatitis B infection reactivationBradycardia (slow heartbeat)FatigueHeadacheNauseaInsomniaDiarrheaItchingDecreased appetiteRash or skin reactions

Daclahep 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Daclahep 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness

Mydekla 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Mydekla 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus.

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness

Myhep Lvir Tablet is a medicine that contains the active substances ledipasvir and sofosbuvir. It is indicated to treat chronic (long-term) hepatitis C virus infection in adults and children three years of age and older. Hepatitis C is a virus that mainly infects the liver. It is mainly triggered by a virus named Flavivirus. Most patients remain asymptomatic, and the symptoms show up only when they develop chronic liver disease or cirrhosis. The progression of liver disease is faster in people who consume alcohol and those with a weak immune system. The main treatment goal for Hepatitis C infection is complete eradication of the virus causing this infection.
This drug is contraindicated for individuals with decompensated cirrhosis or severe liver disease. In such cases, alternative treatment options should be considered. This drug should not be used if you have any known allergy or hypersensitivity to Myhep Lvir Tablet or other ingredients in the medication. Your liver function may change with the treatment of hepatitis C and, therefore, affect other medications (e.g., medicines used to suppress your immune system, etc.). Your doctor may need to monitor your other medicines and make dose adjustments closely. If you have liver disease other than hepatitis C, are awaiting a liver transplant, have a current or previous infection with the hepatitis B virus (HBV), or receive ongoing treatment for HIV infection. It's important to inform your doctor. They will consider these conditions before starting treatment.

Uses
Chronic Hepatitis C virus infection.

Storage
Store the Myhep Lvir Tablet at a controlled room temperature of (30°C).

Side Effects
Allergic reactionsHeadacheTirednessRashes

Natdac 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Natdac 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness

Dacikast 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Dacikast 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness

Dalsiclear 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Dalsiclear 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness

Rifguard tablet is an antibiotic containing the active substance rifaximin. It is used to treat traveller’s diarrhoea caused by noninvasive strains of Escherichia coli in adults and to prevent the recurrence of episodes of overt hepatic encephalopathy (symptomatic loss of brain function) in adults with liver disease. This medicine can be used alone or in combination with medicines containing lactulose.   
Do not take Rifguard tablets if you are allergic to Rifaximin or any of the other ingredients of this medicine. Do not take this medicine if you are allergic to similar types of antibiotics, such as rifamycin, rifampicin, or rifabutin. Do not take this medicine if your physician informs you that you have a blockage in your intestine. Do not take this medicine if you have a fever, blood in stools, or have passed over eight or more unformed stools in the last 24 hours. Inform your physician if you have liver problems before starting the treatment.

Uses
Traveler’s diarrhea.Hepatic encephalopathy.

Storage
Store at room temperature 20° to 25°C.

Side Effects
AnemiaAllergic reactions
Swelling of the legs and feetAbdominal painNauseaAbdominal swellingDizziness, headacheTiredness

Dacihep 60mg tablet contains the active ingredient Daclatasvir. It is an antiviral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used  along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver).  It works by stopping the virus that causes hepatitis C from spreading inside the body. 
Do not take Dacihep 60mg tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine.

Uses
Chronic hepatitis C virus

Storage
Store at room temperature (20°C and 25°C).

Side Effects
Decreased heart rateLiver failureReactivation of hepatitis B virusNauseaHeadacheTirednessDizziness